Researchers developed SNIPRs, innovative receptors that sense soluble ligands, enabling precise therapeutic control in CAR T-cells. This breakthrough enhances tumor targeting while reducing off-target effects, paving the way for advanced synthetic biology applications.
Engineered SNIPRs transform CAR T-cell precision for safer cancer therapy
- Post author:
- Post published:
- Post category:uncategorized